Annual Operating Profit
$780.75 M
+$44.20 M+6.00%
March 31, 2024
Summary
- As of March 2, 2025, RDY annual operating income is $780.75 million, with the most recent change of +$44.20 million (+6.00%) on March 31, 2024.
- During the last 3 years, RDY annual operating profit has risen by +$338.25 million (+76.44%).
- RDY annual operating profit is now at all-time high.
Performance
RDY Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$221.44 M
+$6.05 M+2.81%
December 31, 2024
Summary
- As of March 2, 2025, RDY quarterly operating income is $221.44 million, with the most recent change of +$6.05 million (+2.81%) on December 31, 2024.
- Over the past year, RDY quarterly operating profit has increased by +$18.41 million (+9.06%).
- RDY quarterly operating profit is now at all-time high.
Performance
RDY Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$596.73 M
+$18.41 M+3.18%
December 31, 2024
Summary
- As of March 2, 2025, RDY TTM operating income is $596.73 million, with the most recent change of +$18.41 million (+3.18%) on December 31, 2024.
- Over the past year, RDY TTM operating profit has dropped by -$191.56 million (-24.30%).
- RDY TTM operating profit is now -25.33% below its all-time high of $799.12 million, reached on September 30, 2023.
Performance
RDY TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RDY Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +6.0% | +9.1% | -24.3% |
3 y3 years | +76.4% | +84.4% | +24.1% |
5 y5 years | +175.4% | +84.4% | +24.1% |
RDY Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +76.4% | at high | +84.4% | -25.3% | +28.7% |
5 y | 5-year | at high | +175.4% | at high | +148.3% | -25.3% | +41.1% |
alltime | all time | at high | >+9999.0% | at high | +1526.4% | -25.3% | >+9999.0% |
Dr Reddys Laboratories Limited Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | - | $221.44 M(+2.8%) | $596.73 M(+3.2%) |
Sep 2024 | - | $215.40 M(+34.7%) | $578.32 M(-26.7%) |
Mar 2024 | $780.75 M(+6.0%) | $159.89 M(-21.3%) | $789.19 M(+0.1%) |
Dec 2023 | - | $203.04 M(-4.0%) | $788.29 M(-1.4%) |
Sep 2023 | - | $211.46 M(-1.6%) | $799.12 M(+1.0%) |
Jun 2023 | - | $214.80 M(+35.1%) | $791.23 M(+7.7%) |
Mar 2023 | $736.56 M(+52.8%) | $158.98 M(-25.7%) | $734.45 M(+5.6%) |
Dec 2022 | - | $213.88 M(+5.1%) | $695.58 M(+14.9%) |
Sep 2022 | - | $203.57 M(+28.8%) | $605.20 M(+10.1%) |
Jun 2022 | - | $158.01 M(+31.5%) | $549.86 M(+14.3%) |
Mar 2022 | $482.18 M(+9.0%) | $120.12 M(-2.7%) | $481.04 M(+3.7%) |
Dec 2021 | - | $123.49 M(-16.7%) | $463.81 M(+2.8%) |
Sep 2021 | - | $148.24 M(+66.2%) | $451.11 M(+6.1%) |
Jun 2021 | - | $89.20 M(-13.3%) | $425.03 M(-3.9%) |
Mar 2021 | $442.50 M(-4.1%) | $102.88 M(-7.1%) | $442.26 M(+2.5%) |
Dec 2020 | - | $110.79 M(-9.3%) | $431.41 M(+2.0%) |
Sep 2020 | - | $122.17 M(+14.8%) | $422.80 M(-7.0%) |
Jun 2020 | - | $106.42 M(+15.6%) | $454.65 M(-1.6%) |
Mar 2020 | $461.45 M(+62.8%) | $92.03 M(-9.9%) | $462.17 M(+3.6%) |
Dec 2019 | - | $102.19 M(-33.7%) | $445.93 M(+7.1%) |
Sep 2019 | - | $154.01 M(+35.2%) | $416.18 M(+27.1%) |
Jun 2019 | - | $113.94 M(+50.3%) | $327.36 M(+15.0%) |
Mar 2019 | $283.53 M(+52.0%) | $75.79 M(+4.6%) | $284.55 M(+13.9%) |
Dec 2018 | - | $72.43 M(+11.1%) | $249.89 M(-2.0%) |
Sep 2018 | - | $65.20 M(-8.3%) | $254.88 M(+2.4%) |
Jun 2018 | - | $71.13 M(+72.9%) | $248.82 M(+34.7%) |
Mar 2018 | $186.52 M(-7.9%) | $41.13 M(-46.9%) | $184.78 M(-3.7%) |
Dec 2017 | - | $77.42 M(+30.9%) | $191.83 M(-4.1%) |
Sep 2017 | - | $59.14 M(+734.7%) | $200.02 M(+4.5%) |
Jun 2017 | - | $7.09 M(-85.3%) | $191.50 M(-5.3%) |
Mar 2017 | $202.48 M(-55.4%) | $48.18 M(-43.7%) | $202.23 M(-12.3%) |
Dec 2016 | - | $85.62 M(+69.2%) | $230.50 M(-11.3%) |
Sep 2016 | - | $50.61 M(+184.1%) | $259.85 M(-26.1%) |
Jun 2016 | - | $17.82 M(-76.7%) | $351.76 M(-22.9%) |
Mar 2016 | $454.49 M(+5.1%) | $76.45 M(-33.5%) | $455.98 M(-4.9%) |
Dec 2015 | - | $114.97 M(-19.3%) | $479.50 M(-0.4%) |
Sep 2015 | - | $142.53 M(+16.8%) | $481.19 M(+8.1%) |
Jun 2015 | - | $122.03 M(+22.1%) | $445.31 M(+3.0%) |
Mar 2015 | $432.38 M(+0.3%) | $99.97 M(-14.3%) | $432.19 M(+1.2%) |
Dec 2014 | - | $116.66 M(+9.4%) | $427.09 M(-4.9%) |
Sep 2014 | - | $106.64 M(-2.1%) | $449.31 M(-2.6%) |
Jun 2014 | - | $108.92 M(+14.8%) | $461.19 M(+8.1%) |
Mar 2014 | $431.15 M(+11.8%) | $94.86 M(-31.7%) | $426.67 M(-5.8%) |
Dec 2013 | - | $138.88 M(+17.2%) | $453.04 M(+12.8%) |
Sep 2013 | - | $118.53 M(+59.3%) | $401.58 M(+3.7%) |
Jun 2013 | - | $74.40 M(-38.6%) | $387.10 M(+0.4%) |
Mar 2013 | $385.81 M | $121.23 M(+38.7%) | $385.43 M(+20.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2012 | - | $87.42 M(-16.0%) | $319.61 M(-16.1%) |
Sep 2012 | - | $104.05 M(+43.1%) | $380.91 M(+6.2%) |
Jun 2012 | - | $72.73 M(+31.3%) | $358.65 M(+3.1%) |
Mar 2012 | $382.70 M(+41.8%) | $55.41 M(-62.7%) | $347.83 M(-9.2%) |
Dec 2011 | - | $148.71 M(+81.8%) | $383.16 M(+29.7%) |
Sep 2011 | - | $81.79 M(+32.1%) | $295.50 M(+4.3%) |
Jun 2011 | - | $61.92 M(-31.8%) | $283.20 M(+1.6%) |
Mar 2011 | $269.85 M(+19.6%) | $90.74 M(+48.6%) | $278.84 M(+18.3%) |
Dec 2010 | - | $61.05 M(-12.1%) | $235.71 M(+1.7%) |
Sep 2010 | - | $69.49 M(+20.7%) | $231.72 M(+7.9%) |
Jun 2010 | - | $57.56 M(+20.9%) | $214.85 M(-4.5%) |
Mar 2010 | $225.55 M(-7.5%) | $47.61 M(-16.6%) | $224.96 M(-16.4%) |
Dec 2009 | - | $57.06 M(+8.4%) | $269.15 M(-6.9%) |
Sep 2009 | - | $52.62 M(-22.2%) | $289.20 M(+4.6%) |
Jun 2009 | - | $67.67 M(-26.3%) | $276.58 M(+14.5%) |
Mar 2009 | $243.80 M(+79.5%) | $91.80 M(+19.0%) | $241.54 M(+30.0%) |
Dec 2008 | - | $77.12 M(+92.8%) | $185.86 M(+35.4%) |
Sep 2008 | - | $40.00 M(+22.6%) | $137.23 M(-1.2%) |
Jun 2008 | - | $32.63 M(-9.7%) | $138.94 M(-7.0%) |
Mar 2008 | $135.80 M(-45.6%) | $36.12 M(+26.8%) | $149.36 M(-22.0%) |
Dec 2007 | - | $28.49 M(-31.7%) | $191.38 M(-8.9%) |
Sep 2007 | - | $41.71 M(-3.1%) | $210.00 M(-16.6%) |
Jun 2007 | - | $43.04 M(-44.9%) | $251.79 M(+1.2%) |
Mar 2007 | $249.71 M(+662.2%) | $78.14 M(+65.9%) | $248.92 M(+50.9%) |
Dec 2006 | - | $47.11 M(-43.6%) | $164.99 M(+22.8%) |
Sep 2006 | - | $83.49 M(+107.8%) | $134.38 M(+102.5%) |
Jun 2006 | - | $40.18 M(-794.7%) | $66.36 M(+106.1%) |
Mar 2006 | $32.76 M(-607.4%) | -$5.78 M(-135.1%) | $32.21 M(+43.4%) |
Dec 2005 | - | $16.49 M(+6.5%) | $22.46 M(+424.6%) |
Sep 2005 | - | $15.48 M(+157.3%) | $4.28 M(-587.8%) |
Jun 2005 | - | $6.02 M(-138.8%) | -$877.80 K(-85.2%) |
Mar 2005 | -$6.46 M(-114.2%) | -$15.52 M(+817.4%) | -$5.92 M(-292.5%) |
Dec 2004 | - | -$1.69 M(-116.4%) | $3.07 M(-82.4%) |
Sep 2004 | - | $10.32 M(+954.3%) | $17.42 M(-38.0%) |
Jun 2004 | - | $979.00 K(-115.0%) | $28.09 M(-37.7%) |
Mar 2004 | $45.39 M(-34.1%) | -$6.54 M(-151.6%) | $45.06 M(-28.6%) |
Dec 2003 | - | $12.66 M(-39.7%) | $63.08 M(-0.6%) |
Sep 2003 | - | $20.99 M(+17.0%) | $63.48 M(+3.1%) |
Jun 2003 | - | $17.95 M(+56.2%) | $61.59 M(-10.5%) |
Mar 2003 | $68.90 M(-35.0%) | $11.49 M(-12.0%) | $68.83 M(-7.7%) |
Dec 2002 | - | $13.05 M(-31.7%) | $74.61 M(-19.4%) |
Sep 2002 | - | $19.10 M(-24.2%) | $92.53 M(-23.0%) |
Jun 2002 | - | $25.19 M(+45.9%) | $120.18 M(+13.4%) |
Mar 2002 | $105.94 M(+226.0%) | $17.27 M(-44.3%) | $105.95 M(+19.5%) |
Dec 2001 | - | $30.98 M(-33.7%) | $88.69 M(+53.7%) |
Sep 2001 | - | $46.74 M(+326.1%) | $57.71 M(+426.1%) |
Jun 2001 | - | $10.97 M | $10.97 M |
Mar 2001 | $32.49 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual operating income?
- What is the all time high annual operating profit for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual operating profit year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly operating income?
- What is the all time high quarterly operating profit for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly operating profit year-on-year change?
- What is Dr Reddys Laboratories Limited TTM operating income?
- What is the all time high TTM operating profit for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM operating profit year-on-year change?
What is Dr Reddys Laboratories Limited annual operating income?
The current annual operating profit of RDY is $780.75 M
What is the all time high annual operating profit for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual operating income is $780.75 M
What is Dr Reddys Laboratories Limited annual operating profit year-on-year change?
Over the past year, RDY annual operating income has changed by +$44.20 M (+6.00%)
What is Dr Reddys Laboratories Limited quarterly operating income?
The current quarterly operating profit of RDY is $221.44 M
What is the all time high quarterly operating profit for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly operating income is $221.44 M
What is Dr Reddys Laboratories Limited quarterly operating profit year-on-year change?
Over the past year, RDY quarterly operating income has changed by +$18.41 M (+9.06%)
What is Dr Reddys Laboratories Limited TTM operating income?
The current TTM operating profit of RDY is $596.73 M
What is the all time high TTM operating profit for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM operating income is $799.12 M
What is Dr Reddys Laboratories Limited TTM operating profit year-on-year change?
Over the past year, RDY TTM operating income has changed by -$191.56 M (-24.30%)